ProfileGDS4718 / 240897_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 70% 71% 65% 71% 70% 65% 69% 73% 72% 70% 66% 68% 70% 65% 65% 70% 65% 66% 64% 71% 72% 68% 67% 67% 69% 63% 67% 62% 71% 68% 65% 66% 76% 72% 65% 64% 68% 71% 71% 62% 68% 65% 66% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.8790970
GSM549102patient 115, normal, homogenized [OPG study]6.9470771
GSM549104patient 119, normal, homogenized [OPG study]6.495365
GSM549108patient 138, normal, homogenized [OPG study]6.889771
GSM549119patient 077, normal, homogenized [OPG study]6.839170
GSM549133patient 032, cancer, homogenized [OPG study]6.4698765
GSM549139patient 042, cancer, homogenized [OPG study]6.820769
GSM549099patient 107, normal, homogenized [OPG study]7.1013773
GSM549109patient 139, normal, homogenized [OPG study]7.0533972
GSM549110patient 046, normal, homogenized [OPG study]6.8468670
GSM549114patient 063, normal, homogenized [OPG study]6.52666
GSM549122patient 082, normal, homogenized [OPG study]6.7096968
GSM549134patient 033, cancer, homogenized [OPG study]6.8281170
GSM549136patient 036, cancer, homogenized [OPG study]6.4971665
GSM549140patient 044, cancer, homogenized [OPG study]6.4903465
GSM549111patient 047, normal, homogenized [OPG study]6.8852170
GSM549113patient 057, normal, homogenized [OPG study]6.4971665
GSM549132patient 031, cancer, homogenized [OPG study]6.5524866
GSM549137patient 038, cancer, homogenized [OPG study]6.3974964
GSM549142patient 047, cancer, homogenized [OPG study]6.9110371
GSM549100patient 110, normal, homogenized [OPG study]6.9633972
GSM549107patient 135, normal, homogenized [OPG study]6.6687368
GSM549115patient 068, normal, homogenized [OPG study]6.6756167
GSM549116patient 072, normal, homogenized [OPG study]6.6690867
GSM549120patient 078, normal, homogenized [OPG study]6.7653469
GSM549131patient 030, cancer, homogenized [OPG study]6.3281663
GSM549118patient 074, normal, homogenized [OPG study]6.6277967
GSM549129patient 027, cancer, homogenized [OPG study]6.3249762
GSM549123patient 088, normal, homogenized [OPG study]6.9420471
GSM549124patient 006, cancer, homogenized [OPG study]6.6750768
GSM549126patient 015, cancer, homogenized [OPG study]6.4933465
GSM549128patient 025, cancer, homogenized [OPG study]6.597466
GSM549103patient 117, normal, homogenized [OPG study]7.3266876
GSM549117patient 073, normal, homogenized [OPG study]7.0546172
GSM549138patient 041, cancer, homogenized [OPG study]6.525165
GSM549141patient 045, cancer, homogenized [OPG study]6.4685464
GSM549130patient 028, cancer, homogenized [OPG study]6.7198368
GSM549101patient 111, normal, homogenized [OPG study]6.9657471
GSM549105patient 128, normal, homogenized [OPG study]6.9447671
GSM549106patient 134, normal, homogenized [OPG study]6.2821562
GSM549112patient 048, normal, homogenized [OPG study]6.7162768
GSM549125patient 011, cancer, homogenized [OPG study]6.4975365
GSM549127patient 024, cancer, homogenized [OPG study]6.6267466
GSM549135patient 035, cancer, homogenized [OPG study]6.4782465